Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

996 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Plant Cell Culture-Derived Saponin Adjuvant Enhances Immune Response Against a Stabilized Human Metapneumovirus Pre-Fusion Vaccine Candidate.
Swart M, Allen J, Reed B, Izquierdo Gil A, Verspuij J, Schmit-Tillemans S, Chakkumkal A, Findeis M, Hafner AV, Harjivan C, Kurnat R, Kuipers H, Zahn R, Brandenburg B. Swart M, et al. Among authors: reed b. Vaccines (Basel). 2024 Dec 20;12(12):1435. doi: 10.3390/vaccines12121435. Vaccines (Basel). 2024. PMID: 39772095 Free PMC article.
Addiction Medicine: Opioid Use Disorder.
Carroll Turpin MA, Starks SM, Grissom MO, Reed BC. Carroll Turpin MA, et al. Among authors: reed bc. FP Essent. 2024 Nov;546:29-36. FP Essent. 2024. PMID: 39556473 Review.
Addiction Medicine: Tobacco Use Disorder.
Reed BC, Grissom MO, Carroll Turpin MA, Starks SM. Reed BC, et al. FP Essent. 2024 Nov;546:23-28. FP Essent. 2024. PMID: 39556472 Review.
Addiction Medicine: Alcohol Use Disorder.
Grissom MO, Reed BC, Starks SM, Carroll Turpin MA. Grissom MO, et al. Among authors: reed bc. FP Essent. 2024 Nov;546:7-15. FP Essent. 2024. PMID: 39556470
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial.
Werring DJ, Dehbi HM, Ahmed N, Arram L, Best JG, Balogun M, Bennett K, Bordea E, Caverly E, Chau M, Cohen H, Cullen M, Doré CJ, Engelter ST, Fenner R, Ford GA, Gill A, Hunter R, James M, Jayanthi A, Lip GYH, Massingham S, Murray ML, Mazurczak I, Nash PS, Ndoutoumou A, Norrving B, Sims H, Sprigg N, Vanniyasingam T, Freemantle N; OPTIMAS investigators. Werring DJ, et al. Lancet. 2024 Oct 23:S0140-6736(24)02197-4. doi: 10.1016/S0140-6736(24)02197-4. Online ahead of print. Lancet. 2024. PMID: 39491870 Free article.
996 results